Researchers Develop Versatile Antifibrotic Coating Technology for Biomedical Implants
Researchers have developed a versatile antifibrotic surface coating for biomedical implants that uses photoreactive benzophenone groups to bond polymer chains to a wide range of materials. The coating combines anti-fibrotic small molecules with anti-fouling zwitterionic components, and was tested in mice where it reduced fibrotic capsule thickness by approximately 60% and cut collagen deposition more than 3.5-fold on commercial catheters. Foreign body response — the immune system's tendency to wall off implants with scar tissue — is a leading cause of implant failure, and a broadly applicable solution could improve the longevity and safety of many medical devices.
A team of researchers has reported a new method for coating biomedical implants with an antifibrotic polymer layer designed to suppress the foreign body response, a common complication in which the immune system triggers inflammation and fibrotic capsule formation around implanted devices. The approach uses benzophenone photoreactive groups embedded in designer polymer chains, which covalently bond to substrate surfaces upon UV activation, enabling attachment to a diverse range of biomedical materials. The researchers systematically varied the density of benzophenone groups and the ratio of anti-fibrotic to anti-fouling (zwitterionic) components to identify an optimal polymer composition. In vivo experiments in C57BL/6 mice showed that silicone implants coated with the optimized polymer exhibited roughly 60% thinner fibrotic capsules compared to uncoated controls. When applied to commercial medical catheters implanted in the peritoneal space for four weeks, the coating reduced collagen deposition by more than 3.5-fold. The method was also demonstrated on a variety of other commonly used biomedical materials, underscoring its broad applicability. The study, posted as a preprint on bioRxiv, suggests this platform could serve as a practical tool for improving the performance and longevity of a wide range of implantable medical devices.
What's missing
As a preprint, this work has not yet undergone formal peer review. The study was conducted exclusively in a mouse model (C57BL/6), and it is unclear how well the results will translate to larger animals or humans. Long-term durability of the coating beyond the four-week implantation window was not assessed. Potential toxicity or degradation products of the polymer coating over extended periods were not discussed.
What different sources said
- bioRxivCenter
A Facile and Versatile Technique for Creating Antifibrotic Coatings on Biomedical Implants
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.